295 related articles for article (PubMed ID: 10800488)
1. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1999; 18():268-92. PubMed ID: 10800488
[No Abstract] [Full Text] [Related]
2. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1997; 17():390-407. PubMed ID: 9551222
[No Abstract] [Full Text] [Related]
3. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1991; 12():327-46. PubMed ID: 1931449
[No Abstract] [Full Text] [Related]
4. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1992; 13():327-48. PubMed ID: 1389914
[No Abstract] [Full Text] [Related]
5. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1990; 11():321-42. PubMed ID: 2223398
[No Abstract] [Full Text] [Related]
6. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1988; 10():129-47. PubMed ID: 3079381
[No Abstract] [Full Text] [Related]
7. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1996; 16():347-75. PubMed ID: 8639390
[No Abstract] [Full Text] [Related]
8. Leukemia.
McKenna SJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Feb; 89(2):137-9. PubMed ID: 10673646
[No Abstract] [Full Text] [Related]
9. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1994; 15():391-412. PubMed ID: 7779590
[No Abstract] [Full Text] [Related]
10. Leukemia and myelomatosis.
Catovsky D
Cancer Chemother Biol Response Modif; 1987; 9():134-64. PubMed ID: 3079401
[No Abstract] [Full Text] [Related]
11. [Update on malignant hematologic diseases].
Marie JP; Delmer A
Bull Cancer; 1998 Jan; 85(1):42-4. PubMed ID: 9752345
[No Abstract] [Full Text] [Related]
12. [Treatment of acute and chronic leukemias].
Mandelli F; Montefusco E
Recenti Prog Med; 1999 Nov; 90(11):605-12. PubMed ID: 10608151
[TBL] [Abstract][Full Text] [Related]
13. [Effects of a lymph node extract on hemopoietic and lymphoid cells in normal state and in different forms of leukemia].
Fediakhina RF; Rybakova LP; Tutova IIu
Eksp Onkol; 1990; 12(4):47-50. PubMed ID: 2379487
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
15. [Current status and future perspective of new drugs for hematological malignancies in Japan].
Ogura M
Rinsho Ketsueki; 2007 Oct; 48(10):1442-52. PubMed ID: 17933133
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of leukemia].
Oono R
Nihon Naika Gakkai Zasshi; 1997 Mar; 86(3):477-80. PubMed ID: 9198635
[No Abstract] [Full Text] [Related]
17. A summer of hematologic science. Highlights from the 45th Annual Meeting of the American Society of Clinical Oncology, the 14th Congress of the European Hematology Association, and the 2009 Pan Pacific Lymphoma Conference.
Cheson BD; Ashforth E
Clin Adv Hematol Oncol; 2009 Sep; 7(9 Suppl 15):1-22; quiz 23-4. PubMed ID: 20102012
[No Abstract] [Full Text] [Related]
18. StatBite: Estimated new cases for the four major leukemias, 2008.
J Natl Cancer Inst; 2009 Mar; 101(6):371. PubMed ID: 19276455
[No Abstract] [Full Text] [Related]
19. [Interferons in the treatment of hematological diseases].
Jantunen E; Nousiainen T
Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
[No Abstract] [Full Text] [Related]
20. Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage.
Chaidos A; Kanfer E; Apperley JF
Best Pract Res Clin Haematol; 2007 Jun; 20(2):125-54. PubMed ID: 17448953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
